BROWN ADVISORY INC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1345929 BALTIMORE, MD

Position in DNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$586,731

+$544,103 QoQ

Shares Held

59,206

+1755.4% QoQ

Ownership

0.088%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#59

of 183 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BROWN ADVISORY INC holds $214,822,359 across 27 Biotechnology names. DNA ranks #17 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	1,287,558	$90,965,971
2	CYTK	Cytokinetics Inc	570,664	$48,614,865
3	PCVX	Vaxcyte, Inc.	487,017	$28,310,297
4	ALNY	Alnylam Pharmaceuticals, Inc.	77,398	$23,299,119
5	INSM	INSMED Inc	41,694	$4,445,414
6	VRTX	Vertex Pharmaceuticals Inc / Ma	7,562	$3,756,271
7	REGN	Regeneron Pharmaceuticals, Inc.	5,274	$3,288,549
8	HALO	Halozyme Therapeutics, Inc.	35,881	$2,808,405

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$586,731	59,206	-53.6%	Shares	Defined	2026-08-14
2024-06-30	$42,628	127,629	-46.1%	Shares	Defined	2024-08-14
2024-03-31	$274,787	236,886	-1.1%	Shares	Defined	2024-04-24
2023-12-31	$404,628	239,425	+17.2%	Shares	Defined	2024-02-08
2023-09-30	$369,679	204,243	-16.5%	Shares	Defined	2023-10-25
2023-06-30	$454,861	244,549	+48.0%	Shares	Defined	2023-07-31
2023-03-31	$219,827	165,284	+0.4%	Shares	Defined	2023-05-08
2022-12-31	$278,130	164,574	+14.9%	Shares	Defined	2023-02-13
2022-09-30	$446,905	143,239	+7.4%	Shares	Defined	2022-11-14
2022-06-30	$317,346	133,339	+196.4%	Shares	Defined	2022-11-14
2022-03-31	$181,273	44,981	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.